Cosmos Health Launches US Collagen Skincare Brand Targeting $163 Billion Market
COSM•Cosmos Health has launched a premium Korean-developed collagen-based skincare line in the US under a direct-to-consumer model, with sales live for over a month. The company targets the $163 billion global skincare market and plans a multi-brand rollout to drive higher-margin growth and diversify beyond core healthcare.
1. Premium skincare launch
Cosmos Health has begun selling a Korean-developed, collagen-based skincare line in the United States through a direct-to-consumer platform, with products live for over a month. The company plans a multi-brand rollout designed for global scale, expanding its portfolio beyond pharmaceuticals and nutraceuticals into high-growth beauty categories.
2. Market opportunity and strategic diversification
The global skincare market is estimated at $163 billion in 2026 and projected to reach $203 billion by 2033, with premium skincare among the fastest-growing segments due to rising consumer demand for science-backed formulations. This launch marks a strategic shift toward higher-margin products and faster-growing end markets, aiming to enhance Cosmos Health’s revenue mix and profitability.
